Differentiation of equine bone marrow derived mesenchymal stem cells increases the expression of immunogenic genes.

This research investigates how the process of differentiation, where mesenchymal stem cells (MSCs) transform into distinct cell types, affects their immunogenicity – their ability to provoke an immune response – in horses. The conclusion is that differentiation increases the expression of certain immunogenic genes, with potential implications for the efficacy and safety of treatments involving these cells.

Objectives of the Study

• The primary purpose of the study was to evaluate the gene expression of immunogenic markers – specifically MHC-I, MHC-II, CD40 and CD80 – in mesenchymal stem cells (MSCs) from equine bone marrow, before and after they had differentiated into other cell types.
• This research was conducted in light of growing interest in allogenic therapies, treatments using donated stem cells, which require full understanding of any potential immune response that may be triggered.
• Investigations into such reactions has been done for other species, but not yet studied in equine MSCs.

Methodology of the Research

• In the study, MSCs were extracted from equine bone marrow (4 individual samples).
• The cells were then induced to differentiate into three types of cells: osteoblasts (bone-forming cells), adipocytes (fat cells), and chondrocytes (cartilage cells).
• The researchers then confirmed this differentiation using specific dye staining and by analyzing the expression of genes associated with each cell type.
• During this process, the expression of immunogenic markers – MHC-I, MHC-II, CD40 and CD80 – was continually analyzed.

Findings from the Research

• Significant increases in the gene expression of MHC-I and MHC-II were noted during the differentiation into osteoblasts and adipocytes, but not into chondrocytes.
• The expressions of CD40 and CD80 did not change significantly.
• These findings indicate that the differentiation process, either before or after administration of MSCs within the body, could increase their immunogenicity. This carries potential risks of allorecognition, where the immune system identifies the MSCs as foreign and possibly harmful.

Implications from the Research

• The findings suggest that differentiation of equine MSCs increases their immunogenicity, and this could hamper the effectiveness and safety of allogenic treatments using these cells.
• This calls for further research into how the immunogenic characteristics of MSCs could be managed or mitigated in treatment contexts.
• Additionally, the immunogenic differences between differentiated and undifferentiated MSCs, as well as between different cell types, could be studied further.